Regulatory mechanisms of C4b-binding protein (C4BP)α and β expression in rat hepatocytes by lipopolysaccharide and interleukin-6

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 11, 2008, Pages 1858-1867

  Kishiwada, M ^a,b   Hayashi, T ^a   Yuasa, H ^a,b   Fujii, K ^a,b   Nishioka, J ^a   Akita, N ^a   Tanaka, H ^a   Ido, M ^a   Okamoto, T ^a   Gabazza, E C ^b   Isaji, S ^b   Suzuki, Koji ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C4b binding protein; CD14; Interleukin 6; Lipopolysaccharide; MAP kinase; NFjB, STAT 3; Toll like receptor 4

Indexed keywords

COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT COMPONENT C4B BINDING PROTEIN ALPHA; COMPLEMENT COMPONENT C4B BINDING PROTEIN BETA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; PROTEIN S; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; TIME;

ANIMALS; COMPLEMENT C4B-BINDING PROTEIN; HEPATOCYTES; INTERLEUKIN-6; KINETICS; LIPOPOLYSACCHARIDES; LIVER; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTEIN S; RATS; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR;

EID: 54149108764     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03129.x     Document Type: Article

References (30)

1. Dahlbäck B. Protein S and C4b-binding protein. Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61.
2. Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: Different roles for protein S and the protein S-C4BP binding protein complex. Blood 2004; 103: 1192-201.
3. Walker FJ. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128-31.
4. Vehar GA, Davie EW. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 1980; 19: 401-10.
5. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-7.
6. Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A 1994; 91: 2728-32.
7. Dahlbäck B, Stenflo J. High molecular weight complex in human plasma vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci U S A 1981; 78: 2512-6.
8. Dahlbäck B. Purification of human C4b-binding protein and formation of its complex with vitamin-K dependent protein S. Biochem J 1983; 209: 847-56.
9. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-7.
10. Nishioka J, Suzuki K. Inhibition of cofactor activity of protein S by a complex of protein S and C4b-binding protein. Evidence for inactive ternary complex formation between protein S, C4b-binding protein and activated protein C. J Biol Chem 1990; 265: 9072-6.
11. Gracia de Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost 2008; 98: 543-56.
12. Adachi T. Protein S and protein S deficiency: The most frequent congenital thrombophilia in Japanese. Curr Drug Targets 2005; 6: 585-92.
13. Hayashi T, Kishiwada M, Fujii K, Yuasa H, Nishioka J, Ido M, Gabazza EC, Suzuki K. Lipopolysaccharide-induced decreased PS expression in liver cells is mediated by MEK/ERK signaling and NFκB activation. Involvement of membrane-bound CD14 and Toll-like receptor-4. J Thromb Haemost 2006; 4: 1763-73.
14. Yasuda F, Hayashi T, Tanitame K, Nishioka J, Suzuki K. Molecular cloning and functional characterization of rat protein S. J Biochem (Tokyo) 1995; 117: 374-83.
15. Nishioka J, Suzuki K. Plasma protein S activity measured using Protac, a snake venom derived activator of protein C. Thromb Res 1988; 49: 241-51.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanete-phenol-chlorofrom extraction. Anal Biochem 1987; 162: 156-9.
17. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91.
18. Hillarp A, Wiklund H, Thern A, Dahlbäck B. Molecular cloning of rat C4b binding protein alpha- and beta-chains: Structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins. J Immunol 1997; 158: 1315-23.
19. García de Frutos P, Alim RI, Härdig Y, Zöller B, Dahlbäck B. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994; 84: 815-22.
20. Sánchez-Corral P, Criado García O, Rodríguez de Córdoba S. Isoforms of human C4b-binding protein. I. Molecular basis for the C4BP isoform pattern and its variations in human plasma. J Immunol 1995; 155: 4030-6.
21. Criado-García O, González-Rubio C, López-Trascasa M, Pascual-Salcedo D, Munuera L, Rodríguez de Córdoba S. Modulation of C4b-binding protein isoforms during the acute phase response caused by orthopedic surgery. Haemostasis 1997; 27: 25-34.
22. Saeki T, Hirose S, Nukatsuka M, Kusunoki Y, Nagasawa S. Evidence that C4b-binding protein is an acute phase protein. Biochem Biophys Res Commun 1989; 164: 1446-51.
23. Matsuguchi T, Okamura S, Aso T, Takahashi K, Sata T, Niho Y. Interleukin 6 and tumor necrosis factor fully activate liver-specific gene expression of the alpha chain of C4b-binding protein. Biochem Int 1991; 23: 979-85.
24. Moffat GJ, Tack BF. Regulation of C4b-binding protein gene expression by the acute-phase mediators tumor necrosis factor-alpha, interleukin-6, and interleukin-1. Biochemistry 1992; 31: 12376-84.
25. Criado García O, Sánchez-Corral P, Rodríguez de Córdoba S. Isoforms of human C4b-binding protein. II. Differential modulation of the C4BPA and C4BPB genes by acute phase cytokines. J Immunol 1995; 155: 4037-43.
26. Liu S, Khemlani LS, Shapiro RA, Johnson ML, Liu K, Geller DA, Watkins SC, Goyert SM, Billiar TR. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect Immun 1998; 66: 5089-98.
27. Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, Gambotto AA, Humphris EL, Vodovotz Y, Billiar TR. Role of toll-like receptors in changes in gene expression and NF-κB activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 2002; 70: 3433-42.
28. Nanbo A, Nishimura H, Muta T, Nagasawa S. Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide-binding protein via CD14. Eur J Biochem 1999; 260: 183-91.
29. Dráber P, DráberováL, Heneberg P, Smíd F, Farghali H, Dráber P. Preformed STAT3 transducer complexes in human HepG2 cells and rat hepatocytes. Cell Signal 2007; 19: 2400-12.
30. Albrecht U, Yang X, Asselta R, Keitel V, Tenchini ML, Ludwig S, Heinrich PC, Häussinger D, Schaper F, Bode JG. Activation of NF-kappaB by IL-1beta blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene. Cell Signal 2007; 19: 1866-78.